AUTOMATED RADIATION TARGETING IN HEAD-AND-NECK CANCER USING REGION-BASED TEXTURE ANALYSIS OF PET AND CT IMAGES

Purpose A co-registered multimodality pattern analysis segmentation system (COMPASS) was developed to automatically delineate the radiation targets in head-and-neck cancer (HNC) using both 18 F-fluoro-deoxy glucose-positron emission tomography (PET) and computed tomography (CT) images. The performance of the COMPASS was compared with the results of existing threshold-based methods and radiation oncologist-drawn contours. Methods and Materials The COMPASS extracted texture features from corresponding PET and CT voxels. Using these texture features, a decision-tree–based K-nearest-neighbor classifier labeled each voxel as either “normal” or “abnormal.” The COMPASS was applied to the PET/CT images of 10 HNC patients. Automated segmentation results were validated against the manual segmentations of three radiation oncologists using the volume, sensitivity, and specificity. The performance of the COMPASS was compared with three PET-based threshold methods: standard uptake value of 2.5, 50% maximal intensity, and signal/background ratio. Results The tumor delineations of the COMPASS were both quantitatively and qualitatively more similar to those of the radiation oncologists than the delineations from the other methods. The specificity was 95% ± 2%, 84% ± 9%, 98% ± 3%, and 96% ± 4%, and the sensitivity was 90% ± 12%, 93% ± 10%, 48% ± 20%, and 68% ± 25% for the COMPASS, for a standard uptake value of 2.5, 50% maximal intensity, and signal/background ratio, respectively. The COMPASS distinguished HNC from adjacent normal tissues with high physiologic uptake and consistently defined tumors with large variability in 18 F-fluoro-deoxy glucose uptake, which are often problematic with the threshold-based methods. Conclusion Automated segmentation using texture analysis of PET/CT images has the potential to provide accurate delineation of HNC. This could lead to reduced interobserver variability, reduced uncertainty in target delineation, and improved treatment planning accuracy.